SK

Smitha Kunjan Lexman

Active Director Director DIN 07624397
DIN 07624397 First appointment Sep 2016 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Total affiliations 6 Since Sep 2016
Shareholding value •••• Premium profile

About Smitha Kunjan Lexman

Data last updated:

Smitha Kunjan Lexman is a Director at Sabine Hospital & Research Centre Private Limited (since 2016), Director at Toscana Mercantile Private Limited (since 2018) and Director at Maharaja Medical Centre Pvt Ltd (since 2024), and holds 3 more current directorships. The companies operate in Healthcare, Pharma and Trading. The 5 current companies with reported revenue have a combined latest revenue of ₹234 Cr; the largest is Sabine Hospital & Research Centre Private Limited at ₹166 Cr (FY 2025).

DIN 07624397
Primary Designation Director
Industry Healthcare
First Appointment 30 Sep 2016
Oldest Company Age 36 yrs
Largest company Sabine Hospital & Research Centre Private Limited · ₹166 Cr (FY 2025)
Combined revenue ₹234 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Sep 20162016₹166 Cr (FY 2025)Active
Toscana Mercantile Private Limited U52609KL2018PTC052229
Director05 Mar 20182018₹39.54 Cr (FY 2025)Active
Maharaja Medical Centre Pvt Ltd U85110KL1990PTC005844
Director19 Oct 20241990₹27.34 Cr (FY 2024)Active
Lilac Diagnostics Private Limited U86905KL2023PTC085385
Director29 Dec 20232023₹1.56 Cr (FY 2025)Active
Zapkart Technologies Private Limited U51909KL2019PTC060596
Director03 Dec 20192019₹6,967 (FY 2025)Active
Designated Partner11 Apr 20232023Active

Directorship timeline

Open interactive timeline →
Hubble Infrastructure Llp
Zapkart Technologies Private Limited
Toscana Mercantile Private Limited
Sabine Hospital & Research Centre Private Limited
Premium access

Shareholding and investment profile for Smitha Kunjan Lexman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Smitha Kunjan Lexman

Smitha Kunjan Lexman currently holds 6 directorships: Sabine Hospital & Research Centre Private Limited (Director, since 30 Sep 2016, revenue ₹166 Cr (FY 2025)); Toscana Mercantile Private Limited (Director, since 05 Mar 2018, revenue ₹39.54 Cr (FY 2025)); Maharaja Medical Centre Pvt Ltd (Director, since 19 Oct 2024, revenue ₹27.34 Cr (FY 2024)); Lilac Diagnostics Private Limited (Director, since 29 Dec 2023, revenue ₹1.56 Cr (FY 2025)); Zapkart Technologies Private Limited (Director, since 03 Dec 2019, revenue ₹6,967 (FY 2025)); and 1 more.

Smitha Kunjan Lexman was first appointed on 30 Sep 2016 as Director at Sabine Hospital & Research Centre Private Limited. The most recent appointment on record is 19 Oct 2024 at Maharaja Medical Centre Pvt Ltd.

The 5 current companies of Smitha Kunjan Lexman that report revenue have a combined latest revenue of ₹234 Cr: Sabine Hospital & Research Centre Private Limited ₹166 Cr (FY 2025); Toscana Mercantile Private Limited ₹39.54 Cr (FY 2025); Maharaja Medical Centre Pvt Ltd ₹27.34 Cr (FY 2024); Lilac Diagnostics Private Limited ₹1.56 Cr (FY 2025); Zapkart Technologies Private Limited ₹6,967 (FY 2025).

The current boards of Smitha Kunjan Lexman's companies include Ashish Amit Sharma (Sabine Hospital & Research Centre Private Limited), Ayushi Kesarwani (Sabine Hospital & Research Centre Private Limited), Praveen Santhosh (Sabine Hospital & Research Centre Private Limited), Sabine Sivadasan (Sabine Hospital & Research Centre Private Limited), Santy Neeliyanickal Sajan (Sabine Hospital & Research Centre Private Limited), Vinayak Prabhakar Shenvi (Sabine Hospital & Research Centre Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available